Respiratory disease in rhesus macaques inoculated with SARS-CoV-2
- PMID: 32396922
- PMCID: PMC7486227
- DOI: 10.1038/s41586-020-2324-7
Respiratory disease in rhesus macaques inoculated with SARS-CoV-2
Abstract
An outbreak of coronavirus disease 2019 (COVID-19), which is caused by a novel coronavirus (named SARS-CoV-2) and has a case fatality rate of approximately 2%, started in Wuhan (China) in December 20191,2. Following an unprecedented global spread3, the World Health Organization declared COVID-19 a pandemic on 11 March 2020. Although data on COVID-19 in humans are emerging at a steady pace, some aspects of the pathogenesis of SARS-CoV-2 can be studied in detail only in animal models, in which repeated sampling and tissue collection is possible. Here we show that SARS-CoV-2 causes a respiratory disease in rhesus macaques that lasts between 8 and 16 days. Pulmonary infiltrates, which are a hallmark of COVID-19 in humans, were visible in lung radiographs. We detected high viral loads in swabs from the nose and throat of all of the macaques, as well as in bronchoalveolar lavages; in one macaque, we observed prolonged rectal shedding. Together, the rhesus macaque recapitulates the moderate disease that has been observed in the majority of human cases of COVID-19. The establishment of the rhesus macaque as a model of COVID-19 will increase our understanding of the pathogenesis of this disease, and aid in the development and testing of medical countermeasures.
Conflict of interest statement
Competing interests
The authors declare no competing interests
Figures
Update of
-
Respiratory disease and virus shedding in rhesus macaques inoculated with SARS-CoV-2.bioRxiv [Preprint]. 2020 Mar 21:2020.03.21.001628. doi: 10.1101/2020.03.21.001628. bioRxiv. 2020. Update in: Nature. 2020 Sep;585(7824):268-272. doi: 10.1038/s41586-020-2324-7 PMID: 32511299 Free PMC article. Updated. Preprint.
Similar articles
-
Respiratory disease and virus shedding in rhesus macaques inoculated with SARS-CoV-2.bioRxiv [Preprint]. 2020 Mar 21:2020.03.21.001628. doi: 10.1101/2020.03.21.001628. bioRxiv. 2020. Update in: Nature. 2020 Sep;585(7824):268-272. doi: 10.1038/s41586-020-2324-7 PMID: 32511299 Free PMC article. Updated. Preprint.
-
Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2.Nature. 2020 Sep;585(7824):273-276. doi: 10.1038/s41586-020-2423-5. Epub 2020 Jun 9. Nature. 2020. PMID: 32516797 Free PMC article.
-
Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques.Science. 2020 Aug 14;369(6505):818-823. doi: 10.1126/science.abc5343. Epub 2020 Jul 2. Science. 2020. PMID: 32616673 Free PMC article.
-
Early Insights into Immune Responses during COVID-19.J Immunol. 2020 Aug 1;205(3):555-564. doi: 10.4049/jimmunol.2000526. Epub 2020 Jun 8. J Immunol. 2020. PMID: 32513850 Review.
-
SARS-CoV-2 pathophysiology and assessment of coronaviruses in CNS diseases with a focus on therapeutic targets.Biochim Biophys Acta Mol Basis Dis. 2020 Oct 1;1866(10):165889. doi: 10.1016/j.bbadis.2020.165889. Epub 2020 Jun 27. Biochim Biophys Acta Mol Basis Dis. 2020. PMID: 32603829 Free PMC article. Review.
Cited by
-
SARS-CoV-2 infection dynamics in lungs of African green monkeys.bioRxiv [Preprint]. 2020 Aug 20:2020.08.20.258087. doi: 10.1101/2020.08.20.258087. bioRxiv. 2020. Update in: Sci Transl Med. 2021 Jan 27;13(578):eabe8146. doi: 10.1126/scitranslmed.abe8146 PMID: 32839775 Free PMC article. Updated. Preprint.
-
Erythroid precursors and progenitors suppress adaptive immunity and get invaded by SARS-CoV-2.Stem Cell Reports. 2021 May 11;16(5):1165-1181. doi: 10.1016/j.stemcr.2021.04.001. Stem Cell Reports. 2021. PMID: 33979601 Free PMC article.
-
Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2.NPJ Vaccines. 2021 May 13;6(1):74. doi: 10.1038/s41541-021-00336-1. NPJ Vaccines. 2021. PMID: 33986272 Free PMC article. Review.
-
Baricitinib treatment resolves lower airway inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques.bioRxiv [Preprint]. 2020 Sep 16:2020.09.16.300277. doi: 10.1101/2020.09.16.300277. bioRxiv. 2020. Update in: Cell. 2021 Jan 21;184(2):460-475.e21. doi: 10.1016/j.cell.2020.11.007 PMID: 32995780 Free PMC article. Updated. Preprint.
-
Single-cell transcriptomic atlas of distinct early immune responses induced by SARS-CoV-2 Proto or its variants in rhesus monkey.MedComm (2020). 2023 Nov 20;4(6):e432. doi: 10.1002/mco2.432. eCollection 2023 Dec. MedComm (2020). 2023. PMID: 38020713 Free PMC article.
References
-
- Organization, W. H. Coronavirus disease (COVID-2019) situation reports, <https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situatio...> (2020).
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
